9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      High-resolution mapping of tuberculosis transmission: Whole genome sequencing and phylogenetic modelling of a cohort from Valencia Region, Spain

      research-article
      1 , 2 , 2 , 3 , 4 , 5 , 6 , 7 , 3 , 7 , 5 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 11 , 10 , 16 , 13 , 4 , 17 , 18 , 19 , 20 , 12 , 14 , 19 , 1 , 21 , * , 2 , *
      PLoS Medicine
      Public Library of Science

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Whole genome sequencing provides better delineation of transmission clusters in Mycobacterium tuberculosis than traditional methods. However, its ability to reveal individual transmission links within clusters is limited. Here, we used a 2-step approach based on Bayesian transmission reconstruction to (1) identify likely index and missing cases, (2) determine risk factors associated with transmitters, and (3) estimate when transmission happened.

          Methods and findings

          We developed our transmission reconstruction method using genomic and epidemiological data from a population-based study from Valencia Region, Spain. Tuberculosis (TB) incidence during the study period was 8.4 cases per 100,000 people. While the study is ongoing, the sampling frame for this work includes notified TB cases between 1 January 2014 and 31 December 2016. We identified a total of 21 transmission clusters that fulfilled the criteria for analysis. These contained a total of 117 individuals diagnosed with active TB (109 with epidemiological data). Demographic characteristics of the study population were as follows: 80/109 (73%) individuals were Spanish-born, 76/109 (70%) individuals were men, and the mean age was 42.51 years (SD 18.46). We found that 66/109 (61%) TB patients were sputum positive at diagnosis, and 10/109 (9%) were HIV positive. We used the data to reveal individual transmission links, and to identify index cases, missing cases, likely transmitters, and associated transmission risk factors. Our Bayesian inference approach suggests that at least 60% of index cases are likely misidentified by local public health. Our data also suggest that factors associated with likely transmitters are different to those of simply being in a transmission cluster, highlighting the importance of differentiating between these 2 phenomena. Our data suggest that type 2 diabetes mellitus is a risk factor associated with being a transmitter (odds ratio 0.19 [95% CI 0.02–1.10], p < 0.003). Finally, we used the most likely timing for transmission events to study when TB transmission occurred; we identified that 5/14 (35.7%) cases likely transmitted TB well before symptom onset, and these were largely sputum negative at diagnosis. Limited within-cluster diversity does not allow us to extrapolate our findings to the whole TB population in Valencia Region.

          Conclusions

          In this study, we found that index cases are often misidentified, with downstream consequences for epidemiological investigations because likely transmitters can be missed. Our findings regarding inferred transmission timing suggest that TB transmission can occur before patient symptom onset, suggesting also that TB transmits during sub-clinical disease. This result has direct implications for diagnosing TB and reducing transmission. Overall, we show that a transition to individual-based genomic epidemiology will likely close some of the knowledge gaps in TB transmission and may redirect efforts towards cost-effective contact investigations for improved TB control.

          Author summary

          Why was this study done?
          • To facilitate public health intervention and to design new tuberculosis (TB) control strategies, there is a need to identify when TB is transmitted and by whom.

          • Whole genome sequencing combined with phylogenetic modelling has the potential to fill knowledge gaps on TB epidemiology.

          What did the researchers do and find?
          • We analyzed a population-based cohort of TB patients in Valencia Region, Spain, between 2014 and 2016.

          • We systematically sequenced the whole genomes of culture positive isolates and identified transmission clusters. We combined genomic and epidemiological data to understand how TB is transmitted.

          • We showed that in many cases the index case is likely either not sampled or not the first diagnosed.

          • For a fraction of TB individuals, we could accurately predict when transmission happened. For several transmitters we showed that transmission happened well before diagnosis and symptom onset.

          What do these findings mean?
          • Our findings provide novel insights into TB transmission going beyond cluster delineation.

          • Our results highlight the limitation of contact tracing to identify index cases and can be used to design new TB control strategies.

          • The finding that TB can be transmitted by individuals before they have symptoms, very likely during sub-clinical or incipient disease, has important implications for TB control strategies. More studies are needed to understand the dynamics of TB transmission in different clinical settings.

          • This study highlights the importance of combining genomic data with epidemiological data, in order to gain new insight into how and when TB is transmitted.

          Related collections

          Most cited references23

          • Record: found
          • Abstract: found
          • Article: not found

          Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection.

          SUMMARYTuberculosis (TB) is the leading infectious cause of mortality worldwide, due in part to a limited understanding of its clinical pathogenic spectrum of infection and disease. Historically, scientific research, diagnostic testing, and drug treatment have focused on addressing one of two disease states: latent TB infection or active TB disease. Recent research has clearly demonstrated that human TB infection, from latent infection to active disease, exists within a continuous spectrum of metabolic bacterial activity and antagonistic immunological responses. This revised understanding leads us to propose two additional clinical states: incipient and subclinical TB. The recognition of incipient and subclinical TB, which helps divide latent and active TB along the clinical disease spectrum, provides opportunities for the development of diagnostic and therapeutic interventions to prevent progression to active TB disease and transmission of TB bacilli. In this report, we review the current understanding of the pathogenesis, immunology, clinical epidemiology, diagnosis, treatment, and prevention of both incipient and subclinical TB, two emerging clinical states of an ancient bacterium.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Genotyping of Genetically Monomorphic Bacteria: DNA Sequencing in Mycobacterium tuberculosis Highlights the Limitations of Current Methodologies

            Because genetically monomorphic bacterial pathogens harbour little DNA sequence diversity, most current genotyping techniques used to study the epidemiology of these organisms are based on mobile or repetitive genetic elements. Molecular markers commonly used in these bacteria include Clustered Regulatory Short Palindromic Repeats (CRISPR) and Variable Number Tandem Repeats (VNTR). These methods are also increasingly being applied to phylogenetic and population genetic studies. Using the Mycobacterium tuberculosis complex (MTBC) as a model, we evaluated the phylogenetic accuracy of CRISPR- and VNTR-based genotyping, which in MTBC are known as spoligotyping and Mycobacterial Interspersed Repetitive Units (MIRU)-VNTR-typing, respectively. We used as a gold standard the complete DNA sequences of 89 coding genes from a global strain collection. Our results showed that phylogenetic trees derived from these multilocus sequence data were highly congruent and statistically robust, irrespective of the phylogenetic methods used. By contrast, corresponding phylogenies inferred from spoligotyping or 15-loci-MIRU-VNTR were incongruent with respect to the sequence-based trees. Although 24-loci-MIRU-VNTR performed better, it was still unable to detect all strain lineages. The DNA sequence data showed virtually no homoplasy, but the opposite was true for spoligotyping and MIRU-VNTR, which was consistent with high rates of convergent evolution and the low statistical support obtained for phylogenetic groupings defined by these markers. Our results also revealed that the discriminatory power of the standard 24 MIRU-VNTR loci varied by strain lineage. Taken together, our findings suggest strain lineages in MTBC should be defined based on phylogenetically robust markers such as single nucleotide polymorphisms or large sequence polymorphisms, and that for epidemiological purposes, MIRU-VNTR loci should be used in a lineage-dependent manner. Our findings have implications for strain typing in other genetically monomorphic bacteria.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              PhyResSE: a Web Tool Delineating Mycobacterium tuberculosis Antibiotic Resistance and Lineage from Whole-Genome Sequencing Data.

              Antibiotic-resistant tuberculosis poses a global threat, causing the deaths of hundreds of thousands of people annually. While whole-genome sequencing (WGS), with its unprecedented level of detail, promises to play an increasingly important role in diagnosis, data analysis is a daunting challenge. Here, we present a simple-to-use web service (free for academic use at http://phyresse.org). Delineating both lineage and resistance, it provides state-of-the-art methodology to life scientists and physicians untrained in bioinformatics. It combines elaborate data processing and quality control, as befits human diagnostics, with a treasure trove of validated resistance data collected from well-characterized samples in-house and worldwide.
                Bookmark

                Author and article information

                Contributors
                Role: Formal analysisRole: MethodologyRole: SoftwareRole: VisualizationRole: Writing – original draftRole: Writing – review & editing
                Role: Data curationRole: InvestigationRole: VisualizationRole: Writing – original draftRole: Writing – review & editing
                Role: InvestigationRole: MethodologyRole: Writing – review & editing
                Role: InvestigationRole: MethodologyRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: Resources
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: ConceptualizationRole: Funding acquisitionRole: Project administrationRole: SupervisionRole: Writing – original draftRole: Writing – review & editing
                Role: ConceptualizationRole: Funding acquisitionRole: Project administrationRole: SupervisionRole: Writing – original draftRole: Writing – review & editing
                Role: Academic Editor
                Journal
                PLoS Med
                PLoS Med
                plos
                plosmed
                PLoS Medicine
                Public Library of Science (San Francisco, CA USA )
                1549-1277
                1549-1676
                31 October 2019
                October 2019
                : 16
                : 10
                : e1002961
                Affiliations
                [1 ] Centre for Mathematics of Precision Healthcare, Department of Mathematics, Imperial College London, London, United Kingdom
                [2 ] Instituto de Biomedicina de Valencia, Consejo Superior de Investigaciones Científicas, Valencia, Spain
                [3 ] Genomics and Health Unit, FISABIO Public Health, Valencia, Spain
                [4 ] Microbiology Service, Hospital Clínico Universitario, Valencia, Spain
                [5 ] Microbiology and Parasitology Service, Hospital Universitario de La Ribera, Alzira, Spain
                [6 ] Microbiology Service, Hospital Arnau de Vilanova, Valencia, Spain
                [7 ] Microbiology Service, Hospital Universitario Dr. Peset, Valencia, Spain
                [8 ] Microbiology Laboratory, Hospital Virgen de los Lírios, Alcoy, Spain
                [9 ] Microbiology Service, Hospital de Denia, Denia, Spain
                [10 ] Microbiology Service, Hospital Universitari i Politècnic La Fe, Valencia, Spain
                [11 ] Microbiology Service, Hospital General Universitario de Valencia, Valencia, Spain
                [12 ] Microbiology Service, Hospital General Universitario de Alicante, Alicante, Spain
                [13 ] Microbiology Service, Hospital General Universitario de Castellón, Castellon, Spain
                [14 ] Microbiology Service, Hospital Lluís Alcanyis, Xativa, Spain
                [15 ] Microbiology Service, Hospital General Universitario de Elche, Elche, Spain
                [16 ] Microbiology Service, Hospital Universitario de San Juan de Alicante, Alicante, Spain
                [17 ] Microbiology Service, Hospital de la Vega Baixa, Orihuela, Spain
                [18 ] Microbiology Service, Hospital San Francesc de Borja, Gandía, Spain
                [19 ] Subdirección General de Epidemiología y Vigilancia de la Salud, Dirección General de Salud Pública, Valencia, Spain
                [20 ] Microbiology Service, Hospital de Sagunto, Sagunto, Spain
                [21 ] Department of Mathematics, Simon Fraser University, Burnaby, British Columbia, Canada
                Harvard Medical School, UNITED STATES
                Author notes

                The authors have declared that no competing interests exist.

                ‡ These authors are joint senior authors on this work.

                Author information
                http://orcid.org/0000-0002-2337-3999
                http://orcid.org/0000-0002-8352-180X
                http://orcid.org/0000-0001-5743-9768
                http://orcid.org/0000-0002-9863-6319
                http://orcid.org/0000-0003-1654-3619
                http://orcid.org/0000-0002-3721-848X
                http://orcid.org/0000-0002-4418-3676
                http://orcid.org/0000-0003-3728-3182
                http://orcid.org/0000-0003-2858-2711
                http://orcid.org/0000-0003-1156-9203
                http://orcid.org/0000-0002-7271-3558
                http://orcid.org/0000-0001-8007-5739
                http://orcid.org/0000-0001-6097-6708
                Article
                PMEDICINE-D-19-01205
                10.1371/journal.pmed.1002961
                6822721
                31671150
                93ece558-2a21-469f-9e42-4f0aed7afde6
                © 2019 Xu et al

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 1 April 2019
                : 7 October 2019
                Page count
                Figures: 5, Tables: 1, Pages: 20
                Funding
                Funded by: funder-id http://dx.doi.org/10.13039/100010663, H2020 European Research Council;
                Award ID: 638553-TB-ACCELERATE
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/501100010198, Ministerio de Economía, Industria y Competitividad, Gobierno de España;
                Award ID: SAF2016-77346-R
                Award Recipient :
                Funded by: Engineering and Physical Sciences Research Council (GB)
                Award ID: EP/K026003/1
                Award Recipient :
                Funded by: Engineering and Physical Sciences Research Council (GB)
                Award ID: EP/N014529/1
                Award Recipient :
                IC was supported by European Research Council (638553-TB-ACCELERATE), the Ministerio de Economía y Competitividad (SAF2016-77346-R). CC and YX were supported by the Engineering and Physical Sciences Research Council of the UK (EPSRC EP/K026003/1 (CC) and EPSRC EP/N014529/1 (CC and YX). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Research Article
                Medicine and Health Sciences
                Infectious Diseases
                Bacterial Diseases
                Tuberculosis
                Medicine and Health Sciences
                Tropical Diseases
                Tuberculosis
                Biology and Life Sciences
                Genetics
                Gene Identification and Analysis
                Genetic Networks
                Computer and Information Sciences
                Network Analysis
                Genetic Networks
                Medicine and Health Sciences
                Diagnostic Medicine
                Tuberculosis Diagnosis and Management
                Medicine and Health Sciences
                Infectious Diseases
                Infectious Disease Control
                Biology and Life Sciences
                Evolutionary Biology
                Evolutionary Systematics
                Phylogenetics
                Phylogenetic Analysis
                Biology and Life Sciences
                Taxonomy
                Evolutionary Systematics
                Phylogenetics
                Phylogenetic Analysis
                Computer and Information Sciences
                Data Management
                Taxonomy
                Evolutionary Systematics
                Phylogenetics
                Phylogenetic Analysis
                Medicine and Health Sciences
                Epidemiology
                Medical Risk Factors
                Medicine and Health Sciences
                Epidemiology
                Medicine and Health Sciences
                Epidemiology
                Infectious Disease Epidemiology
                Medicine and Health Sciences
                Infectious Diseases
                Infectious Disease Epidemiology
                Custom metadata
                All the sequence data are deposited in the European Nucleotide Archive under the Bioproject number PRJEB29604 ( https://www.ebi.ac.uk/ena/data/view/PRJEB29604) and the accession numbers ERR2099780 ( https://www.ebi.ac.uk/ena/data/search?query=ERR2099780) and ERR2099784 ( https://www.ebi.ac.uk/ena/data/search?query=ERR2099784).

                Medicine
                Medicine

                Comments

                Comment on this article